Previous Close | 6.81 |
1-Year Change | -0.73% |
6-Months Change | 12.75% |
3-Months Change | -10.39% |
Moving Avg (50d) | 7.0038 |
Moving Avg (200d) | 6.5228 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 279.2M |
Beta (3-Years) | 0.99 |
Revenue Growth (ttm) | -12.85% |
Net Profit Margin (ttm) | -83.02% |
Return On Assets (ttm) | -82.77% |
EPS (ttm) | -6.03 |
PE Ratio (ttm) | -1.13 |
Dividend Yield | % |
Asset Description: | AngioDynamics, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-11-05 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
6.605 | 6.403 | 6.268 | 6.066 | 5.729 | 5.392 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.